Discovery of potent and orally bioavailable heterocycle-based cannabinoid CB1 receptor agonists

被引：5

作者：

Kiyoi, Takao ^{[1
]}

Adam, Julia M. ^{[1
]}

Clark, John K. ^{[1
]}

Davies, Keneth ^{[1
]}

Easson, Anna-Marie ^{[1
]}

Edwards, Darren ^{[1
]}

Feilden, Helen ^{[1
]}

Fields, Ruth ^{[1
]}

Francis, Stuart ^{[1
]}

Jeremiah, Fiona ^{[1
]}

McArthur, Duncan ^{[1
]}

Morrison, Angus J. ^{[1
]}

Prosser, Alan ^{[1
]}

Ratcliffe, Paul D. ^{[1
]}

Schulz, Jurgen ^{[1
]}

Wishart, Grant ^{[1
]}

Baker, James ^{[2
]}

Campbell, Robert ^{[2
]}

Cottney, Jean E. ^{[2
]}

Deehan, Maureen ^{[2
]}

Epemolu, Ola ^{[2
]}

Evans, Louise ^{[2
]}

机构：

[1] Merck Res Labs, Dept Chem, MSD, Newhouse ML1 5SH, Lanark, Scotland

[2] Merck Res Labs, Dept Pharmacol, MSD, Newhouse ML1 5SH, Lanark, Scotland

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2011年 / 21卷 / 06期

关键词：

Cannabinoid; CB1 receptor agonist; Oral bioavailability; NITRILE SULFIDES; DRUG DISCOVERY; PAIN; INDOLE-3-CARBOXAMIDES; GENERATION; DESIGN; MODELS;

D O I：

10.1016/j.bmcl.2011.01.082

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Novel 3-(1H-indol-3-yl)-1,2,4-oxadiazoles and -thiadiazoles were synthesized and found to be potent CB1 cannabinoid receptor agonists. The oral bioavailability of these compounds could be dramatically improved by optimization studies of the side chains attached to the indole and oxadiazole cores, leading to identification of a CB1 receptor agonist with good oral activity in a range of preclinical models of antinociception and antihyperalgesia. (C) 2011 Elsevier Ltd. All rights reserved.

引用

页码：1748 / 1753

页数：6

共 50 条

[1] Discovery of potent and orally bioavailable heterocycle-based β3-adrenergic receptor agonists, potential therapeutics for the treatment of obesity
Lafontaine, Jennifer A.
Day, Robert F.
Dibrino, Joe
Hadcock, John R.
Hargrove, Diane M.
Linhares, Michael
Martin, Kelly A.
Maurer, Tristan S.
Nardone, Nancy A.
Tess, David A.
DaSilva-Jardine, Paul
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (18) : 5245 - 5250
[2] Synthesis and characterization of potent and selective agonists of the neuronal cannabinoid receptor (CB1)
Hillard, CJ
Manna, S
Greenberg, MJ
Dicamelli, R
Ross, RA
Stevenson, LA
Murphy, V
Pertwee, RG
Campbell, WB
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1999, 289 (03): : 1427 - 1433
[3] Discovery of orally bioavailable cannabinoid agonists for the treatment of pain
Beckett, R. P.
Ralbovsky, J. L.
Luo, R.
Cowan, Conrad L.
Foster, R.
Henault, C.
Shelekhin, T.
Rakhilina, L.
Abriola, L.
Gardell, L. R.
Labissiere, G.
Spencer, R. H.
Menzaghi, F.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 238
[4] Rational drug design of potent agonists and antagonists for the CB1 cannabinoid receptor.
Shim, JY
Collantes, ER
Welsh, WJ
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 214 : 77 - COMP
[5] Two distinct classes of novel pyrazolinecarboxamides as potent cannabinoid CB1 receptor agonists
Lange, Jos H. M.
Attali, Amos
van der Neut, Martina A. W.
Wals, Henri C.
Mulder, Arie
Zilaout, Hicham
Duursma, Ate
van Aken, Hans H. M.
van Vliet, Bernard J.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (17) : 4992 - 4998
[6] Discovery of orally active, potent, and selective CB1 antagonists
Jayne, Charles L.
Xia, Yan
Vaccaro, Henry A.
Chackalamannil, Samuel
Greenlee, William
Boykow, George
Duffy, Ruth
Kowalski, Timothy
Spar, Brian
Cui, Xiaoming
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244
[7] Discovery of Potent Dual PPARα Agonists/CB1 Ligands
Perez-Fernandez, Ruth
Fresno, Nieves
Macias-Gonzalez, Manuel
Elguero, Jose
Decara, Juan
Giron, Rocio
Rodriguez-Alvarez, Ana
Isabel Martin, Maria
Rodriguez de Fonseca, Fernando
Goya, Pilar
ACS MEDICINAL CHEMISTRY LETTERS, 2011, 2 (11): : 793 - 797
[8] Recent CB1 Cannabinoid Receptor Antagonists and Inverse Agonists
Seltzman, Herbert H.
DRUG DEVELOPMENT RESEARCH, 2009, 70 (08) : 601 - 615
[9] MEDI 6-Discovery of potent, water soluble CB1 receptor agonists
Adam, Julia M.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 232
[10] Tetrahydroindazole derivatives as potent and peripherally selective cannabinoid-1 (CB1) receptor inverse agonists
Matthews, Jay M.
McNally, James J.
Connolly, Peter J.
Xia, Mingde
Zhu, Bin
Black, Shawn
Chen, Cailin
Hou, Cuifen
Liang, Yin
Tang, Yuting
Macielag, Mark J.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (21) : 5346 - 5349

← 1 2 3 4 5 →